Liyona Kampel1,2,3,4,5,6,7, Meir Goldsmith3,4,5,6,7, Srinivas Ramishetti3,4,5,6,7, Nuphar Veiga3,4,5,6,7, Daniel Rosenblum3,4,5,6,7, Anna Gutkin3,4,5,6,7, Sushmita Chatterjee3,4,5,6,7, Moran Penn1, Galya Lerman1, Dan Peer3,4,5,6,7, Nidal Muhanna1,2
1The Head and Neck Cancer Research Laboratory, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
2The Department of Otolaryngology, Head and Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel
3Laboratory of Precision NanoMedicine, Tel Aviv University, Tel Aviv, Israel
4Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
5Department of Materials Sciences & Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel
6Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel
7Cancer Biology Research Center, Tel Aviv University, Tel Aviv, Israel
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid based nanoparticles